Cipla, Gayatri Projects and RITES to see some action today

Cipla Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 500087 | NSE: CIPLA

25 Sep 2020 Evaluate

Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Dimethyl Fumarate DR Capsules 120mg, 240mg and 120mg/240mg Starter Pak from the United States Food and Drug Administration (USFDA). The company’s Dimethyl Fumarate DR Caps 120mg, 240mg and 120mg/240mg Starter Pak is AB-rated generic therapeutic equivalent version of Biogen IDEC Inc.’s Tecfidera.

Gayatri Projects has received the Letter of Award (LoA) from the Odisha Mining Corporation (OMC) on September 23, 2020. The scope of the work is Mine Operator - Hiring of Plant and Mining Machineries for Excavation/raising of ROM by drilling and blasting, transportation of ROM to crushing and/or screening plant to be installed by the Agency, crushing &/or screening of ROM to obtain finished product of 10-40 mm CLO & -10 mm Iron Ore Fines, transport of finished product to specified yards after necessary weighment, cleaning of quarry faces, disposal of sub grade and Over Burden (OB) including associated rejects / spoils / spurious materials to the specified yards, etc.

RITES has been awarded Turnkey contract for construction of Road Over Bridges (ROBs) in replacement of existing level crossings on competition basis from Railway Board amounting to Rs 205.85 crore. An Memorandum of Understanding (MoU) will be executed between RITES and South Central Railway (SCR) in this regard in due course. This turnkey contract covers construction of 4 nos. of ROBs in replacement of level crossings in Vijaywada division of SCR on Vijaywada-Vishakhapatnam section in the state of Andhra Pradesh.

Ramco Cements has entered into a Memorandum of Understanding (MoU) with Government of Tamil Nadu for setting up an Apex Skill Development Centre (ASDC) at Ariyalur for imparting high-end skill training in the Construction and Infrastructure sector. The establishment of this Apex Skill Development Centre would help the rural employable youths in providing high end sector skill development training, engaging with industries and other stake holders to design and development of industry relevant training curriculum, create a pool of qualified and professional trainers and to act as a Centre of Excellence for the sector.

Mahindra & Mahindra (M&M) has increased its shareholding in Sampo Rosenlew from 49.14% to upto 74.97%. With this, Sampo would become a subsidiary of the Company. The company has been a shareholder in Sampo Rosenlew since July 2016.

Tata Consultancy Services (TCS) has partnered with Maurices, a women’s fashion-apparel retail chain in the US and Canada, to help create a new flexible and scalable IT landscape for the latter. Maurices selected TCS as its digital transformation partner to help build its greenfield IT ecosystem that will optimize more than 200 existing applications and software components in the next 17 months of their transformational journey.

J Kumar Infraprojects has received Letter of Acceptance from MMRDA for External Facade Works for 4 Elevated Stations viz. Aarey, Dindoshi, Kurar and Poisar of line 7 (Andheri East to Dahisar East) of Mumbai Metro Rail Project of MMRDA worth Rs 49.83 crore and another Letter of Acceptance received from DMRC for External Façade Works of 04 Elevated Stations i.e. Goregaon, Adarsh Nagar, Shastri Nagar & D.N. Nagar of Line 2A on Dahisar (East) to DN Nagar Corridor of Mumbai Metro Rail Project, Mumbai for Rs 41.17crore.

Cipla Share Price

1333.55 -1.30 (-0.10%)

05-May-2026 16:59 View Price Chart

Peers

Company Name	CMP
Sun Pharma Inds.	1820.75
Dr. Reddys Lab	1270.95
Cipla	1333.55
Zydus Lifesciences	911.85
Lupin	2343.40
View more..

Cipla, Gayatri Projects and RITES to see some action today

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.